Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study
Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study. // Metabolism Open. – URL: https://www.sciencedirect.com/science/article/pii/S2589936826000678?dgcid=rss_sd_all
Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study. Metabolism Open. https://www.sciencedirect.com/science/article/pii/S2589936826000678?dgcid=rss_sd_all
“Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study.” Metabolism Open.
@article{article58724,
title = {Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study},
journal = {Metabolism Open},
url = {https://www.sciencedirect.com/science/article/pii/S2589936826000678?dgcid=rss_sd_all}
}